Krystal Biotech at TD Cowen Conference: Strategic Growth and Challenges

Entity Intersection Graph

No entity connections available yet for this article.

}

Original Source

              On Tuesday, 03 March 2026, Krystal Biotech (NASDAQ:KRYS) participated in the TD Cowen 46th Annual Health Care Conference. The company highlighted its strategic growth initiatives, focusing on the expansion of VYJUVEK sales and pipeline advancements while acknowledging potential challenges in pricing negotiations and regulatory processes.
            

Read full article at source